An open-label prospective study to assess metabolic side effects with atypical and typical antipsychotic drugs in patients with schizophrenia
Background: Schizophrenia is a major psychiatric illness comprising thought, perception, emotion, movement, and behaviour. Pharmacotherapy plays an important role in managing this disorder, comprising mostly typical and atypical antipsychotics. Treatment with antipsychotics can cause metabolic side...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2014-01-01
|
| Series: | Archives of Mental Health |
| Subjects: | |
| Online Access: | http://www.amhonline.org/article.asp?issn=2589-9171;year=2014;volume=15;issue=2;spage=245;epage=250;aulast=Neredumilli;type=0 |